Literature DB >> 24966017

Discriminatory power of a 25-item distress screening tool: a cross-sectional survey of 251 cancer survivors.

Melissa F Miller1, C Daniel Mullins, Eberechukwu Onukwugha, Mitch Golant, Joanne S Buzaglo.   

Abstract

OBJECTIVE: The objective was to test the discriminatory power of a 25-item distress screening tool for use among cancer survivors. We used a measure of item discrimination to determine which items perform better than others at identifying those at greatest risk of distress.
METHODS: A total of 251 members (90 % female, median age 57 years) of a community-based cancer support organization completed a web-based distress screening tool. Participants were asked to rate each of 25 items according to the question "Today, how concerned are you about…?" using a five-point Likert scale (0 not at all to 4 very seriously concerned). An overall distress score was calculated as the sum of items rated at or above two for somewhat concerned. Participants were categorized as high scorers (≥13, n = 59) and low scorers (≤4, n = 60). The item discrimination index (IDI) was calculated for each item as the percentage difference in concerned (somewhat or greater) responses between high and low scorers.
RESULTS: Items with the greatest discriminatory power (IDI ≥0.8) were as follows: changes or disruptions in work, school or home life; feeling sad or depressed; feeling too tired to do the things you need or want to do; worrying about the future and what lies ahead; and feeling nervous or afraid. Conversely, items with the lowest IDI included considering taking your own life; eating and nutrition; tobacco or substance use; and transportation to treatment and appointments.
CONCLUSION: The results highlight, among 25 items of a community-based distress screening tool, items with the greatest discriminatory power to identify cancer survivors with psychosocial distress. Results suggest targeted screening items to identify those most at risk for distress and priority areas for support services.

Entities:  

Mesh:

Year:  2014        PMID: 24966017     DOI: 10.1007/s11136-014-0742-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

Review 1.  What happens now? Psychosocial care for cancer survivors after medical treatment completion.

Authors:  Annette L Stanton
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

2.  The Genetics Concept Assessment: a new concept inventory for gauging student understanding of genetics.

Authors:  Michelle K Smith; William B Wood; Jennifer K Knight
Journal:  CBE Life Sci Educ       Date:  2008       Impact factor: 3.325

3.  Does screening for distress efficiently uncover meetable unmet needs in cancer patients?

Authors:  Corinne van Scheppingen; Maya J Schroevers; Ans Smink; Yvette M van der Linden; Véronique E Mul; Johannes A Langendijk; James C Coyne; Robbert Sanderman
Journal:  Psychooncology       Date:  2011-03-06       Impact factor: 3.894

4.  Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments.

Authors:  T J Meyer; M M Mark
Journal:  Health Psychol       Date:  1995-03       Impact factor: 4.267

Review 5.  Screening for distress and unmet needs in patients with cancer: review and recommendations.

Authors:  Linda E Carlson; Amy Waller; Alex J Mitchell
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

6.  Can the Distress Thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool.

Authors:  Alex J Mitchell; Elena A Baker-Glenn; Lorraine Granger; Paul Symonds
Journal:  Psychooncology       Date:  2010-02       Impact factor: 3.894

Review 7.  Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis.

Authors:  Hermann Faller; Michael Schuler; Matthias Richard; Ulrike Heckl; Joachim Weis; Roland Küffner
Journal:  J Clin Oncol       Date:  2013-01-14       Impact factor: 44.544

Review 8.  Bone up on osteoporosis. Development of the Facts on Osteoporosis Quiz.

Authors:  R L Ailinger; D C Harper; H A Lasus
Journal:  Orthop Nurs       Date:  1998 Sep-Oct       Impact factor: 0.913

9.  Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage.

Authors:  L E Carlson; A Waller; S L Groff; L Zhong; B D Bultz
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

Review 10.  Screening for emotional distress in cancer patients: a systematic review of assessment instruments.

Authors:  Andrea Vodermaier; Wolfgang Linden; Christopher Siu
Journal:  J Natl Cancer Inst       Date:  2009-10-13       Impact factor: 13.506

View more
  4 in total

1.  Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.

Authors:  Ruben Mesa; Carole B Miller; Maureen Thyne; James Mangan; Sara Goldberger; Salman Fazal; Xiaomei Ma; Wendy Wilson; Dilan C Paranagama; David G Dubinski; John Boyle; John O Mascarenhas
Journal:  BMC Cancer       Date:  2016-02-27       Impact factor: 4.430

2.  A Randomized Controlled Trial Testing the Effectiveness of Coping with Cancer in the Kitchen, a Nutrition Education Program for Cancer Survivors.

Authors:  Melissa Farmer Miller; Zhongyu Li; Melissa Habedank
Journal:  Nutrients       Date:  2020-10-15       Impact factor: 5.717

3.  Using a Quality Improvement Model to Implement Distress Screening in a Community Cancer Setting.

Authors:  Nancy Jo Bush; Joy R Goebel; Kholoud Hardan-Khalil; Kayo Matsumoto
Journal:  J Adv Pract Oncol       Date:  2020-11-01

Review 4.  Assessing unmet needs in advanced cancer patients: a systematic review of the development, content, and quality of available instruments.

Authors:  Ben Rimmer; Lisa Crowe; Adam Todd; Linda Sharp
Journal:  J Cancer Surviv       Date:  2021-08-06       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.